Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T N Chase

Showing results (41-50 of 397) with videos related to

Pageof 40
Sort By:
Gene Therapy|June 1, 1997
Gene therapy for Parkinson's disease: current knowledge and future perspectiveM M Mouradian, T N Chase
Annual Review of Pharmacology|January 1, 1973
Serotonin and central nervous system functionT N Chase, D L Murphy
Advances in Pharmacology and Chemotherapy|January 1, 1975
L-Dopa and the treatment of extrapyramidal diseaseE W Pelton, T N Chase
Clinical Neuropharmacology|August 1, 1988
Central mechanisms and levodopa response fluctuations in Parkinson's diseaseM M Mouradian, T N Chase
Lancet (London, England)|December 4, 1971
Probenecid test in Parkinson's diseaseT N Chase, L K Ng
Neuroscience Letters|December 19, 1988
Dextromethorphan does not protect against quinolinic acid neurotoxicity in rat striatumT M Engber, T N Chase
Archives of Neurology|December 1, 1972
Central monoamine metabolism in Parkinson's diseaseT N Chase, L K Ng
Diseases of the Nervous System|February 1, 1973
Intellectual and memory function in parkinsonian and non-parkinsonian patients treated with L-dopaE F Donnelly, T N Chase
European Journal of Pharmacology|March 15, 1988
Behavioral effects of chronic exposure to selective D-1 and D-2 dopamine receptor agonistsA R Braun, T N Chase
Advances in Pharmacology and Chemotherapy|January 1, 1970
Neurohumoral mechanisms in the brain sliceR I Katz, T N Chase
Pageof 40

Showing results (41-50 of 397) with videos related to

Sort By:
Pageof 40
Gene Therapy|June 1, 1997
Gene therapy for Parkinson's disease: current knowledge and future perspectiveM M Mouradian, T N Chase
Annual Review of Pharmacology|January 1, 1973
Serotonin and central nervous system functionT N Chase, D L Murphy
Advances in Pharmacology and Chemotherapy|January 1, 1975
L-Dopa and the treatment of extrapyramidal diseaseE W Pelton, T N Chase
Clinical Neuropharmacology|August 1, 1988
Central mechanisms and levodopa response fluctuations in Parkinson's diseaseM M Mouradian, T N Chase
Lancet (London, England)|December 4, 1971
Probenecid test in Parkinson's diseaseT N Chase, L K Ng
Neuroscience Letters|December 19, 1988
Dextromethorphan does not protect against quinolinic acid neurotoxicity in rat striatumT M Engber, T N Chase
Archives of Neurology|December 1, 1972
Central monoamine metabolism in Parkinson's diseaseT N Chase, L K Ng
Diseases of the Nervous System|February 1, 1973
Intellectual and memory function in parkinsonian and non-parkinsonian patients treated with L-dopaE F Donnelly, T N Chase
European Journal of Pharmacology|March 15, 1988
Behavioral effects of chronic exposure to selective D-1 and D-2 dopamine receptor agonistsA R Braun, T N Chase
Advances in Pharmacology and Chemotherapy|January 1, 1970
Neurohumoral mechanisms in the brain sliceR I Katz, T N Chase
Pageof 40